BSR response to report from the Public Accounts Committee into Services for People with RA 23 February 2010
BSR statement on NICE decision on use of Certolizumab pegol for rheumatoid arthritis 21 January 2010
BSR Statement on NAO Report: Services for People with Rheumatoid Arthritis 15 July 2009
Swine Flu and Patients on Anti-TNF 14 July 2009
NICE Appraisal for adalimumab, etanercept and infliximab for RA after failure of a previous anti-TNF 24 Nov 2008
ARMA's statement on NICE's decision on switching Anti-TNF for RA 21 July 2008
BSR response to the Health Select Committee report on MMC 9 May 2008
BSR statement in support of the Lancet Report on NICE 8 May 2008
BSR statement on alcohol and arthritis May 2008
BSR statement on sequential use of adalimumab, etanercept and infliximab for rheumatoid arthritis April 2008
BSR statement on NICE Appeal Committee decision on Abatacept for rheumatoid arthritis April 2008
BSR statement on gout February 2008
BSR statement on Lumiracoxib 19 November 2007
BSR statement on NICE decision on Rituximab for rheumatoid arthritis 22 August 2007
BSR statement on NICE document on Abatacept for rheumatoid arthritis 2 August 2007
BSR statement on NICE appeal for alternative anti-TNF 12 June 2007
BSR statement on launch of Musculoskeletal Services Framework (MSF) 1 November 2006
EMEA Announcement on NSAIDS 25 October 2006
Statement on Choose and Book keywords & clinic types 16 October 2006
BSR Statement on Musculoskeletal Services Framework 8 September 2006
NPSA reissues Methotrexate guidance July 2006